iBionext Growth Fund, a Paris, France-based venture capital fund launched in early 2016, which specializes in the creation and development of innovative healthcare startups, announced a first closing of €46m.
The fund, whose target is to reach approximately €100m, has drawn interest from international investors, insurance companies and family offices, alongside the Biotech & Healthcare Acceleration Fund (FABS) operated by Bpifrance in the context of the Investments for the Future Program (PIA) managed by General Commissariat for Investment (CGI).
Created as an extension of iBionext network established in 2012, iBionext Growth Fund aims to invest in innovative healthcare companies developing high potential disruptive technologies with highly unmet medical needs in the fields of biotech, medtech and connected medical devices.
Led by Bernard Gilly, President and Founder, and Alexia Perouse, CEO & Managing Partner, iBionext has invested in seven companies since 2012, including Pixium Vision (Euronext: PIX) GenSight Biologics (Euronext: SIGHT), and Gecko Biomedical.
FinSMEs
07/09/2016